Kornitzer Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.68M | Hold |
278,314
| – | – | 0.11% | 214 |
|
|
2025
Q1 | $5.57M | Sell |
278,314
-105,660
| -28% | -$2.12M | 0.11% | 211 |
|
|
2024
Q4 | $10.2M | Sell |
383,974
-23,264
| -6% | -$620K | 0.2% | 143 |
|
|
2024
Q3 | $11.6M | Sell |
407,238
-135,636
| -25% | -$3.87M | 0.21% | 131 |
|
|
2024
Q2 | $11.8M | Hold |
542,874
| – | – | 0.22% | 125 |
|
|
2024
Q1 | $12M | Hold |
542,874
| – | – | 0.22% | 138 |
|
|
2023
Q4 | $11.7M | Sell |
542,874
-105,350
| -16% | -$2.27M | 0.23% | 135 |
|
|
2023
Q3 | $10.9M | Hold |
648,224
| – | – | 0.23% | 137 |
|
|
2023
Q2 | $8.89M | Hold |
648,224
| – | – | 0.17% | 190 |
|
|
2023
Q1 | $14.7M | Sell |
648,224
-68,020
| -9% | -$1.55M | 0.29% | 98 |
|
|
2022
Q4 | $16.9M | Buy |
716,244
+92,048
| +15% | +$2.17M | 0.34% | 80 |
|
|
2022
Q3 | $16.3M | Sell |
624,196
-17,316
| -3% | -$452K | 0.35% | 74 |
|
|
2022
Q2 | $14.1M | Buy |
641,512
+197,170
| +44% | +$4.33M | 0.28% | 113 |
|
|
2022
Q1 | $19.9M | Hold |
444,342
| – | – | 0.33% | 99 |
|
|
2021
Q4 | $19M | Buy |
444,342
+100,525
| +29% | +$4.31M | 0.28% | 124 |
|
|
2021
Q3 | $22.9M | Hold |
343,817
| – | – | 0.35% | 86 |
|
|
2021
Q2 | $25.2M | Buy |
343,817
+77,940
| +29% | +$5.72M | 0.38% | 82 |
|
|
2021
Q1 | $18.2M | Buy |
265,877
+92,115
| +53% | +$6.31M | 0.29% | 126 |
|
|
2020
Q4 | $11.7M | Buy |
173,762
+13,387
| +8% | +$899K | 0.2% | 177 |
|
|
2020
Q3 | $8.25M | Buy |
160,375
+24,895
| +18% | +$1.28M | 0.16% | 197 |
|
|
2020
Q2 | $5.11M | Buy |
+135,480
| New | +$5.11M | 0.1% | 249 |
|